Metformin suppresses inflammation and apoptosis of myocardiocytes by inhibiting autophagy in a model of ischemia-reperfusion injury

Metformin (Met) is a major widely used oral glucose lowering drug for the treatment of type 2 diabetes. It is reported that metformin could regulate autophagy in various diseases of cardiovascular system including in I/R injury, diabetic cardiomyopathy and heart failure. Autophagy plays a controvers...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kai-yu, Que, Jia-qun, Hu, Ze-song, Yu, Yong-wei, Zhou, Ying-ying, Wang, Lei, Xue, Yang-jing, Ji, Kang-ting, Zhang, Xin-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415420/
https://www.ncbi.nlm.nih.gov/pubmed/32792857
http://dx.doi.org/10.7150/ijbs.40823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415420/
https://www.ncbi.nlm.nih.gov/pubmed/32792857
http://dx.doi.org/10.7150/ijbs.40823

Ejemplares similares